ASP9853, an inhibitor of inducible nitric oxide synthase dimerization, in combination with docetaxel: preclinical investigation and a Phase I study in advanced solid tumors
Crossref DOI link: https://doi.org/10.1007/s00280-016-2967-0
Published Online: 2016-01-25
Published Print: 2016-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Luke, Jason J.
LoRusso, Patricia
Shapiro, Geoffrey I.
Krivoshik, Andrew
Schuster, Robin
Yamazaki, Takao
Arai, Yukinori
Fakhoury, Allam
Dmuchowski, Carl
Infante, Jeffrey R.
Text and Data Mining valid from 2016-01-25